A Comprehensive Evaluation of Iron Therapy in Pregnant Women: Efficacy and Adverse Drug Reaction in the Department of Obstetrics and Gynecology at Integral Institute of Medical Science and Research
Abstract:
Background: Iron deficiency anemia poses a significant medical challenge during pregnancy, being the most prev alent issue. Objective: The study aimed to evaluate iron therapy's uses and potential adverse reactions in pregnant women.
Material and Method: This was the prospective observational study, hundred pregnant anemic women (age above 18 years) with varying degrees of moderate and severe anemia participated, following institutional ethical approval. All patients were monitored for laboratory response and adverse effects. In this study, Statistical Package for the Social Sciences software was utilized.
Results: The study included patients aged 18-45 years (100%). Among the most number of patients were from age group of 25-31 (52%). Among hundred cases fifty patients were moderate and the remaining fifty were severely anemic. Iron was administered parenterally (17.6%) and orally (82.4%). While hemoglobin levels increased in both groups, the parenteral group exhibited a significantly (p-value <0.001) higher percentage increase of 55% after treatment, while in the oral group 20% increase was found after treatment.
Conclusion: Parenteral iron therapy proves more efficacious than oral iron therapy for managing iron deficiency anemia during pregnancy.
